KLI: 3-(5-benzyl-1,2,4-oxadiazol-3-yl)-6-fluoro-1-[2-fluoro-4-(trifluoromethyl)benzyl]-7-(4-methylpiperazin-1-yl)quinolin-4(1H)-one
KLI is a Ligand Of Interest in 3UDL designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 3UDL_KLI_D_571 | 76% | 38% | 0.085 | 0.92 | 1.27 | 1.17 | 2 | 8 | 1 | 0 | 100% | 1 |
| 3UDL_KLI_C_571 | 66% | 39% | 0.097 | 0.902 | 1.25 | 1.14 | 2 | 6 | 0 | 0 | 100% | 1 |
| 3UDL_KLI_A_571 | 63% | 37% | 0.099 | 0.894 | 1.26 | 1.21 | 2 | 5 | 0 | 0 | 100% | 1 |
| 3UDL_KLI_B_571 | 55% | 37% | 0.111 | 0.879 | 1.29 | 1.19 | 2 | 6 | 3 | 0 | 100% | 1 |
